Loading clinical trials...
Loading clinical trials...
The objective of the study is to find the optimal dose of once daily oral neladenoson bialanate (BAY1067197) when given in addition to appropriate therapy for specific comorbidities.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bayer
NCT03999138 · Acute Heart Failure, Pulmonary Edema With Heart Failure
NCT03103932 · Heart Failure; With Decompensation
NCT06762964 · Fontan Circulation, Single Ventricle Heart Disease, and more
NCT04347655 · Heart Failure
NCT07083011 · Heart Failure With Preserved Ejection Fraction
Northwestern University
Chicago, Illinois
St. Louis Heart & Vascular, PC
St Louis, Missouri
BryanLGH Medical Center East
Lincoln, Nebraska
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions